Microbial Growth in the Suture Thread, After Application of Different Antiseptic Gels in Mandibular Third Molars Extraction

NCT03188289 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2017-06-15

No results posted yet for this study

Summary

This is a randomized clinical trial in which investigators will compare the antimicrobial effect and inducer of cicatrization as well as the degree of postoperative pain in patients who are extracted the lower third molars.

After the surgery, different bioadhesive gels will be applied in the area of the surgical wound and we will evaluate the aforementioned parameters.

Conditions

  • Wisdom Teeth
  • Oral Surgery
  • Third Molar Surgery
  • Bioadhesive Gel
  • Suture Bacteria
  • Antiseptic Gel
  • Chistosan
  • Clorhexidine Gel Bacteria
  • Clorhexidine-chitosan
  • Bacterial Growth

Interventions

DRUG

Placebo gel

Placebo is the control group treated with a placebo gel.

DRUG

Clorhexidine gel

Clorhexidine will be compare with placebo, clorhexidine-chitosán and hyaluronic acid bioadhesive gels

DRUG

Clorhexidine-Chitosan gel

Clorhexidine-chitosan will be compare with placebo, clorhexidine and hyaluronic acid bioadhesive gels.

DRUG

Hyaluronic Acid gel

Hyaluronic acid will be compare with placebo, clorhexidine, clorhexidine-chitosan bioadhesive gels

Sponsors & Collaborators

  • University of Santiago de Compostela

    lead OTHER

Principal Investigators

  • Samuel Rodríguez Zorrilla, DDS,MSc · University of Santiago de Compostela

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
39 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-01-20
Primary Completion
2014-07-15
Completion
2014-09-10

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03188289 on ClinicalTrials.gov